Venture Life Group Plc (VLG)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Venture Life Group Plc (VLG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013380
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Venture Life Group Plc (Venture Life) is a consumer goods company that offers ageing population products. The company’s product range and pipeline comprise food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin. It also offers development and manufacturing services to companies in the medical device and cosmetic sectors. Venture Life conducts research in the therapeutic areas of cardiovascular, neurology, dermatology, rheumatology and ophthalmology. The company markets its products in the UK and abroad. Venture Life is headquartered in Bracknell, the UK.

Venture Life Group Plc (VLG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Venture Life Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Venture Life Group Plc, Medical Devices Deals, 2011 to YTD 2017 9
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
OptiBiotix Health Enters into an Agreement with Venture Life 11
Venture Life Enters into Distribution Agreement with DEEF Pharma 12
Venture Life Enters into Distribution Agreement with Hikma Pharma 13
Venture Life Enters into Distribution Agreement with Pharma Deen 14
Venture Life Enters into Distribution Agreement with Moorfields Pharma 15
Equity Offering 16
Venture Life Group Raises USD9 Million in IPO 16
Acquisition 17
Venture Life Group Acquires Biokosmes 17
Venture Life Group Plc – Key Competitors 18
Venture Life Group Plc – Key Employees 19
Venture Life Group Plc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Venture Life Group Plc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Venture Life Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Venture Life Group Plc, Deals By Therapy Area, 2011 to YTD 2017 8
Venture Life Group Plc, Medical Devices Deals, 2011 to YTD 2017 9
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
OptiBiotix Health Enters into an Agreement with Venture Life 11
Venture Life Enters into Distribution Agreement with DEEF Pharma 12
Venture Life Enters into Distribution Agreement with Hikma Pharma 13
Venture Life Enters into Distribution Agreement with Pharma Deen 14
Venture Life Enters into Distribution Agreement with Moorfields Pharma 15
Venture Life Group Raises USD9 Million in IPO 16
Venture Life Group Acquires Biokosmes 17
Venture Life Group Plc, Key Competitors 18
Venture Life Group Plc, Key Employees 19
Venture Life Group Plc, Subsidiaries 20

★海外企業調査レポート[Venture Life Group Plc (VLG)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Iliad S.A. (ILD):企業の財務・戦略的SWOT分析
    Iliad S.A. (ILD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Aptevo Therapeutics Inc (APVO):製薬・医療:M&Aディール及び事業提携情報
    Summary Aptevo Therapeutics Inc (Aptevo), a subsidiary of Emergent Biosolutions Inc, is a biotechnology company that develops and commercializes oncology and hematology therapeutics. The company’s only marketed product Ixinity that is indicated to replace the missing clotting factor IX in adults and …
  • Stellar Resources Ltd
    Stellar Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Stellar Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Fraser & Neave Holdings Bhd:戦略・SWOT・企業財務分析
    Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report Summary Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Pall Corp-医療機器分野:企業M&A・提携分析
    Summary Pall Corp (Pall), a subsidiary of Danaher Corporation, is a supplier of filtration, separation and purification products and technologies to remove solid, liquid and gaseous contaminants from liquids and gases. Its major products include biochemicals, bioreactors, breathers, canisters, cartr …
  • Martifer SGPS SA (MAR):企業の財務・戦略的SWOT分析
    Martifer SGPS SA (MAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Countrywide Plc:企業のM&A・事業提携・投資動向
    Countrywide Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Countrywide Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Yiaco Medical Co:企業の戦略的SWOT分析
    Yiaco Medical Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Krka, d. d., Novo mesto:戦略・SWOT・企業財務分析
    Krka, d. d., Novo mesto - Strategy, SWOT and Corporate Finance Report Summary Krka, d. d., Novo mesto - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • QuadraMed Corp:企業の戦略的SWOT分析
    QuadraMed Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Nobel Biocare Services AG:企業の戦略的SWOT分析
    Nobel Biocare Services AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • China Billion Resources Limited:企業の戦略・SWOT・財務情報
    China Billion Resources Limited - Strategy, SWOT and Corporate Finance Report Summary China Billion Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Amsted Industries Inc:企業の戦略・SWOT・財務分析
    Amsted Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Amsted Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Danfoss AS:企業の戦略的SWOT分析
    Danfoss AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Stealth BioTherapeutics Corp (MITO):企業の財務・戦略的SWOT分析
    Stealth BioTherapeutics Corp (MITO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Saudi Electricity Co:企業の発電所・SWOT分析2018
    Saudi Electricity Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Fairfield Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Fairfield Energy Ltd (Fairfield Energy), a subsidiary of Decom Energy Ltd is an oil and gas company that offers oil and gas decommissioning services. The company acquires and develops hydrocarbon properties. It acquires and operates marginal fields in the UK continental shelf. Fairfield Ener …
  • M3, Inc. (2413):企業の財務・戦略的SWOT分析
    M3, Inc. (2413) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Celon Pharma SA (CLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Celon Pharma SA (Celon Pharma), subsidiary of Glatton Sp zoo, is an integrated pharmaceutical company that carries out research and develops new medicines. The company provides product portfolio such as Aromek, Salmex, Valzek, Lazivir, Bosentan Celon, Donepex and Ketrel, among others. It pri …
  • American Shared Hospital Services (AMS):医療機器:M&Aディール及び事業提携情報
    Summary American Shared Hospital Services (ASHS) is a healthcare company that offers medical equipment to hospitals and medical centers. The company offers financial and healthcare tech solutions. Its financing solutions comprise feasibility studies and reimbursement analysis, facilities planning an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆